Innovative companies will be able to trial new health products in clinical settings across the country following a link-up between the Scottish Government’s £42 million Techscaler programme and the NHS.
Participants in the programme, which provides world class expertise and support to young businesses with high growth potential, are being offered access to NHS Regional Test Beds. These enable entrepreneurs to work alongside clinicians and have access to patients and anonymised data to test ideas, products and services.
And in a reciprocal agreement, firms already using the NHS Test Beds will automatically become part of the Techscaler network.
Wellbeing Economy Secretary Neil Gray announced the move during a visit to Bioliberty in Edinburgh, which uses robotics to provide rehabilitation and assistance for stroke survivors. The company will be one of 14 firms in sectors including healthtech and life sciences to join a Scottish Government-funded visit to New York to showcase their work.
Mr Gray said: “Scotland’s life sciences sector has an annual turnover of more than £8 billion and is one of our key sectors for transformative economic growth. This partnership will be able to leverage our world-leading universities, life sciences hubs and excellent healthcare systems to support the growth of the sector and development of entrepreneurs.
“Testing products in a real world environment and accelerating development is vital, and will enable a broader reach of the Tech Scaler programme. This in turn will benefit patients and medical staff as they develop cutting-edge technology for use across the NHS, from stroke and rehabilitation through to reducing drug-related deaths.
The Techscaler network was recommended as part of Mark Logan’s Technology ecosystem review.